These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39043357)

  • 1. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.
    Lu Z; Ngan MP; Liu JYH; Yang L; Tu L; Chan SW; Giuliano C; Lovati E; Pietra C; Rudd JA
    Physiol Behav; 2024 Oct; 284():114644. PubMed ID: 39043357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiemetic effect of a potent and selective neurokinin-1 receptor antagonist, FK886, on cisplatin-induced acute and delayed emesis in ferrets.
    Furukawa TY; Nakayama H; Imazumi K; Yamakuni H; Takeshita K; Matsuo M; Manda T; Uchida W
    Biol Pharm Bull; 2014; 37(2):232-8. PubMed ID: 24492720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
    Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
    Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets.
    Tattersall FD; Rycroft W; Cumberbatch M; Mason G; Tye S; Williamson DJ; Hale JJ; Mills SG; Finke PE; MacCoss M; Sadowski S; Ber E; Cascieri M; Hill RG; MacIntyre DE; Hargreaves RJ
    Neuropharmacology; 2000 Feb; 39(4):652-63. PubMed ID: 10728886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.
    Tsuchiya M; Fujiwara Y; Kanai Y; Mizutani M; Shimada K; Suga O; Ueda S; Watson JW; Nagahisa A
    Pharmacology; 2002 Nov; 66(3):144-52. PubMed ID: 12372904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.
    Rudd JA; Naylor RJ
    Br J Pharmacol; 1996 May; 118(2):209-14. PubMed ID: 8735616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of ghrelin and des-acyl ghrelin in chemotherapy-induced nausea and vomiting.
    Yang L; Kung CJS; Lu Z; Liu JYH; Ngan MP; Sakai T; Sakata I; Chan SW; Tu L; Rudd JA
    Neuropharmacology; 2024 Jun; 251():109919. PubMed ID: 38548221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
    Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
    Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret.
    Fukunaka N; Sagae S; Kudo R; Endo T; Hirafuji M; Minami M
    Gen Pharmacol; 1998 Nov; 31(5):775-81. PubMed ID: 9809477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
    Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
    Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
    Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
    Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
    Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
    Goineau S; Guillaume P; Barrais L; Castagné V
    Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
    Yamakuni H; Sawai-Nakayama H; Imazumi K; Maeda Y; Matsuo M; Manda T; Mutoh S
    Eur J Pharmacol; 2002 May; 442(3):273-8. PubMed ID: 12065081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting anti-emetic effect of T-2328, a novel NK(1) antagonist.
    Watanabe Y; Okamoto M; Ishii T; Takatsuka S; Taniguchi H; Nagasaki M; Saito A
    J Pharmacol Sci; 2008 Jun; 107(2):151-8. PubMed ID: 18544900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret.
    Sam TS; Kan KK; Ngan MP; Rudd JA; Yeung JH
    Eur J Pharmacol; 2003 Apr; 466(1-2):163-8. PubMed ID: 12679153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
    Rudd JA; Jordan CC; Naylor RJ
    Br J Pharmacol; 1996 Nov; 119(5):931-6. PubMed ID: 8922742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three preclinical models for nausea and vomiting assessment.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets.
    Yoshikawa T; Yoshida N; Oka M
    Eur J Pharmacol; 2001 Nov; 431(3):361-4. PubMed ID: 11730730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret.
    Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Lin G; Rudd JA
    Toxicol Lett; 2010 Feb; 192(3):402-7. PubMed ID: 19931602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.